Health Trials

Idiopathic Immune Complex-Mediated Glomerulonephritis

1

Review clinical trials related to Idiopathic Immune Complex-Mediated Glomerulonephritis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN

The purpose of this study is to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of OMS906 in patients with C3 Glomerulopathy (C3G) and Idiopathic Immune Complex-Mediated Glomerulonephritis (ICGN)

Participants needed: 20
Trial details
Phase: Phase 2Age: 18-99Biological sex: AllType: InterventionalSponsor: Omeros CorporationUpdated: Jul 15, 2025Locations: 6
Eligibility criteria

Male or female adults 18 years and older. [+12]

History of major organ transplant or hematopoietic stem cell/marrow transplant. [+18]

Read more